Aug 28, 2025 07:44PM
Apr 6, 2025 08:03PM
Oct 30, 2024 07:00AM
Sep 16, 2024 04:01PM
Sep 16, 2024 04:01PM
Jun 5, 2024 07:01AM
Jun 5, 2024 07:00AM I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
Nov 2, 2023 08:00AM
Nov 1, 2023 08:00AM
Oct 31, 2023 04:01PM
Oct 16, 2023 08:00AM
Oct 13, 2023 03:12PM
Aug 14, 2023 04:02PM
Jul 11, 2023 08:04AM TRACON Pharmaceutical (TCON) Announces Collection of Arbitration Award from I-Mab Biopharma (IMAB)
Jul 11, 2023 08:00AM
Jul 5, 2023 08:03AM
Jul 5, 2023 08:00AM
Jun 20, 2023 08:00AM
May 25, 2023 08:00AM
May 10, 2023 04:02PM
Apr 25, 2023 07:42AM TRACON Pharmaceutical (TCON) Announces Arbitration Award in Dispute with I-Mab (IMAB)
Apr 25, 2023 07:41AM
Apr 11, 2023 06:00AM
Mar 31, 2023 06:32AM
Mar 31, 2023 06:30AM
Mar 8, 2023 04:02PM
Dec 14, 2022 08:02AM
Dec 14, 2022 08:00AM TRACON Pharmaceuticals Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial
Nov 14, 2022 04:02PM
Aug 30, 2022 06:01AM
Aug 30, 2022 06:00AM
Aug 10, 2022 04:02PM
Jul 22, 2022 08:00AM
Jun 14, 2022 04:04PM
Jun 14, 2022 04:01PM MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
May 12, 2022 11:39AM
May 11, 2022 04:02PM
Apr 20, 2022 09:23AM
Mar 29, 2022 06:12AM
Mar 29, 2022 06:10AM
Mar 15, 2022 04:03PM
Mar 15, 2022 04:02PM TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
Mar 3, 2022 08:01AM
Mar 3, 2022 08:00AM
Feb 24, 2022 04:01PM
Feb 2, 2022 07:43AM
Jan 28, 2022 08:08AM
Jan 28, 2022 08:00AM
Dec 20, 2021 08:00AM I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization
Dec 14, 2021 05:48AM

322,203 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All